Your browser doesn't support javascript.
loading
Rare ocular toxicity induced by pertuzumab/QL1209 in healthy chinese subjects: case reports and whole-exome sequencing analysis.
Ma, Junlong; Chen, Wenjing; Hu, Zhanqing; Huang, Jie; Guo, Chengxian; Zou, Chan; Yang, Guoping.
Afiliación
  • Ma J; Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
  • Chen W; Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
  • Hu Z; Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
  • Huang J; Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
  • Guo C; Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
  • Zou C; Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. zouchan@csu.edu.cn.
  • Yang G; Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. ygp9880@126.com.
Invest New Drugs ; 40(4): 861-867, 2022 08.
Article en En | MEDLINE | ID: mdl-35596833
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Prognostic_studies País/Región como asunto: Asia Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Tipo de estudio: Prognostic_studies País/Región como asunto: Asia Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article